NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 10742.25 137.90 1.30%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bayer AG (ETR: BAYN)

 
BAYN Technical Analysis
3
As on 1st Nov 2017 BAYN Share Price closed @ 114.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 108.90 & Buy for SHORT-TERM with Stoploss of 112.14 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BAYN Share Price

Open 113.45 Change Price %
High 114.80 1 Day 2.90 2.60
Low 112.80 1 Week 0.00 0.00
Close 114.60 1 Month -2.55 -2.18
Volume 2221376 1 Year 20.70 22.04
52 Week High 123.90 | 52 Week Low 86.03
 
ETR Germany Most Active Stocks
DTE 15.31 -2.11%
DBK 14.13 1.29%
EOAN 10.38 2.47%
CBK 11.88 0.93%
IFX 24.51 4.30%
LHA 28.21 2.96%
DAI 73.07 2.50%
BIR 0.24 0.00%
TKA 23.49 2.53%
MEO 29.18 0.00%
 
ETR Germany Top Gainers Stocks
S9H 0.16 45.45%
M3B 0.84 21.74%
CR8 7.33 20.16%
R3Q 0.12 20.00%
5M71 39.00 13.70%
WI4 1.12 13.13%
KU2 210.50 11.97%
SONA 35.85 11.75%
SONA 35.85 11.75%
ELG 27.09 11.53%
 
ETR Germany Top Losers Stocks
MPI 0.25 -98.98%
MPI 0.25 -98.98%
APL 2.60 -34.18%
APL 2.60 -34.18%
APL 2.60 -34.18%
U9R 10.60 -24.56%
BIO 24.70 -11.41%
BIO 24.70 -11.41%
BIO 24.70 -11.41%
BIO 24.70 -11.41%
 
 
BAYN
Daily Charts
BAYN
Intraday Charts
Whats New @
Bazaartrend
BAYN
Free Analysis
 
BAYN Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE116.45
RESISTANCE115.69
SUPPORT113.51
SUPPORT112.75
SUPPORT0.00
SUPPORT0.00
 
BAYN Target for Month February
4th UP TARGET130.3
3rd UP TARGET124.33
2nd UP TARGET120.65
1st UP TARGET116.96
1st DOWN TARGET106.44
2nd DOWN TARGET102.75
3rd DOWN TARGET99.07
4th DOWN TARGET93.1
 
BAYN Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
BAYN Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
BAYN Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.bayer.com
 
BAYN Address
BAYN
Kaiser-Wilhelm-Allee 1
Leverkusen, 51368
Germany
Phone: 49 214 301
 
BAYN Latest News
 
Your Comments and Response on Bayer AG
 
BAYN Business Profile
Bayer Aktiengesellschaft develops, produces, and markets health care and agricultural products, and high-tech polymer materials worldwide. The company operates through HealthCare, CropScience, and MaterialScience segments. The HealthCare segment offers prescription pharmaceuticals, such as contraceptives, hemophilia treatments, anticoagulants, and medicines to treat multiple sclerosis, cancer, hypertension, and infectious diseases; and consumer health products comprising over-the-counter medications, dermatology products, nutritional supplements, veterinary medicines, and animal grooming products. This segment also provides medical care products, including blood glucose monitoring devices, such as single-strip and multi-strip systems; USB meters that feature integrated diabetes management software and direct plug-in to computers; contrast agent injection systems for diagnostic and therapeutic medical procedures in computed tomography, magnetic resonance imaging, and molecular imaging; and mechanical systems for removing thrombi from blood vessels, as well as service products for its systems. The CropScience segment offers products for use in agriculture as insecticides, fungicides, and herbicides or seed treatments; seeds and plant traits; and various products for gardens, green industry, and nonagricultural pest control. The MaterialScience segment provides high-tech polymer materials in the areas of polyurethanes, polycarbonates, coating and adhesive raw materials, and functional films; and produces and markets inorganic basic chemicals. The company has a strategic alliance with OncoMed Pharmaceuticals, Inc. to develop drugs to target cancer stem cell therapeutics. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
 
2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service